Celsius (CELH) had the highest return between August 5, 2014 and July 1, 2015 by a US stock with a market cap of $2B+, returning 296.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Celsius (CELH) | 8/5/2014 - 7/1/2015 | 296.86% |
Ambarella (AMBA) | 8/5/2014 - 7/1/2015 | 265.29% |
Neurocrine Biosciences (NBIX) | 8/5/2014 - 7/1/2015 | 252.25% |
Amicus Therapeutics (FOLD) | 8/5/2014 - 7/1/2015 | 240.29% |
Axon Enterprise (AXON) | 8/5/2014 - 7/1/2015 | 188.77% |
Paycom Soft (PAYC) | 8/5/2014 - 7/1/2015 | 173.43% |
Globant (GLOB) | 8/5/2014 - 7/1/2015 | 157.44% |
Corcept Therapeutics (CORT) | 8/5/2014 - 7/1/2015 | 154.24% |
CyberArk Software (CYBR) | 8/5/2014 - 7/1/2015 | 149.08% |
Halozyme Therapeutics (HALO) | 8/5/2014 - 7/1/2015 | 147.52% |
Ultragenyx (RARE) | 8/5/2014 - 7/1/2015 | 130.95% |
Installed Building Products (IBP) | 8/5/2014 - 7/1/2015 | 127.61% |
CleanSpark (CLSK) | 8/5/2014 - 7/1/2015 | 125% |
Credit Acceptance (CACC) | 8/5/2014 - 7/1/2015 | 122.93% |
Dycom Industries (DY) | 8/5/2014 - 7/1/2015 | 122.58% |
Centene (CNC) | 8/5/2014 - 7/1/2015 | 122.44% |
Coca-Cola Consolidated (COKE) | 8/5/2014 - 7/1/2015 | 120.93% |
Palo Alto Networks (PANW) | 8/5/2014 - 7/1/2015 | 120.84% |
Incyte (INCY) | 8/5/2014 - 7/1/2015 | 117.74% |
TG Therapeutics (TGTX) | 8/5/2014 - 7/1/2015 | 117.21% |
Skechers (SKX) | 8/5/2014 - 7/1/2015 | 115.63% |
Biomarin Pharmaceutical (BMRN) | 8/5/2014 - 7/1/2015 | 113.94% |
NexGen Energy (NXE) | 8/5/2014 - 7/1/2015 | 113.8% |
Builders FirstSource (BLDR) | 8/5/2014 - 7/1/2015 | 113.1% |
Alnylam Pharmaceuticals (ALNY) | 8/5/2014 - 7/1/2015 | 112.91% |
